SYVN1 and neoplasm: Partial least-square-discriminant analysis (PLS-DA) was performed, which revealed an obvious separate metabolic trend in tumour samples compared to the SYVN1 knockdown and control samples (Supplementary Fig. 5A; Supplementary Table 1).